A nurse is providing teaching to a client who is initiating oral contraceptive use. Which of the following client conditions is a contraindication for oral contraceptive use?

Choice A reason: Providing transportation information is helpful but does not directly coordinate care, as it addresses access rather than securing services. Coordination involves arranging specific care delivery, so this action is supportive but less comprehensive, making it incorrect for demonstrating care coordination.
Choice B reason: Encouraging self-advocacy empowers the client but does not actively coordinate care, which requires arranging services or resources. This action is educational, not logistical, and does not ensure access to health services, making it incorrect for this context.
Choice C reason: Informing about providers who accept insurance is informative but not sufficient for coordination, which involves facilitating actual care delivery. Without arranging services, this action remains preparatory, making it less effective than directly securing an appointment, thus incorrect.
Choice D reason: Arranging an appointment with a mobile health clinic directly facilitates access to care, addressing rural barriers. This active coordination ensures the client receives services, aligning with case management principles for underserved populations, making it the correct demonstration of care coordination.

Choice A reason: Bilirubin assesses liver function, not kidneys. Cyclosporine’s nephrotoxicity affects glomerular filtration, not heme metabolism. Monitoring bilirubin is irrelevant for renal function in transplant clients, as it reflects hepatic or hemolytic processes, not kidney health or drug toxicity.
Choice B reason: Alkaline phosphatase evaluates liver or bone health, not kidneys. Cyclosporine may cause hepatotoxicity, but renal monitoring is critical due to its nephrotoxic potential. Alkaline phosphatase does not reflect glomerular or tubular function, making it unsuitable for assessing renal impact.
Choice C reason: Amylase measures pancreatic function, not kidneys. Cyclosporine’s nephrotoxicity affects renal filtration, not pancreatic enzymes. Monitoring amylase is irrelevant for kidney transplant clients, as it does not indicate renal impairment or cyclosporine’s toxic effects on kidney function.
Choice D reason: Creatinine is a key renal function marker, reflecting glomerular filtration rate. Cyclosporine’s nephrotoxicity elevates creatinine, indicating kidney damage. Monitoring it with BUN ensures early detection of renal impairment, guiding dose adjustments to prevent further injury in transplant clients.